Justin Hall is CEO, GC and Director of NovaBay Pharmaceuticals, Inc.. Currently has a direct ownership of 83,172 shares of NBY, which is worth approximately $55,725. The most recent transaction as insider was on Sep 14, 2022, when has been sold 10,000 shares (Common Stock) at a price of $0.15 per share, resulting in proceeds of $1,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.2K
0% 3M change
0% 12M change
Total Value Held $55,725

Justin Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 14 2022
BUY
Open market or private purchase
$1,500 $0.15 p/Share
10,000 Added 10.73%
83,172 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$30,000 $0.43 p/Share
69,767 Added 48.81%
73,172 Common Stock
JH

Justin Hall

CEO, GC and Director
Emeryville, CA

Track Institutional and Insider Activities on NBY

Follow NovaBay Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBY shares.

Notify only if

Insider Trading

Get notified when an Nova Bay Pharmaceuticals, Inc. insider buys or sells NBY shares.

Notify only if

News

Receive news related to NovaBay Pharmaceuticals, Inc.

Track Activities on NBY